Claritev (CTEV) Non-Current Deffered Revenue (2020)

Claritev's (CTEV) quarterly Non-Current Deffered Revenue came in at $38.5 million in Q3 2020, little changed quarter-over-quarter from $38.5 million in Q2 2020.

Claritev (CTEV) Non-Current Deffered Revenue (2020) Analysis & Trends

Claritev's Non-Current Deffered Revenue history runs 1 years deep, the most recent figure standing at $38.5 million for Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Veeva Systems 31.99 Bn 24.68 Bn 662.02 Mn -
2 BrightSpring Health Services 14.73 Bn 13.83 Bn 482.22 Mn 4.57 Mn
3 Healthequity 8.31 Bn 8.04 Bn 256.31 Mn -
4 Hinge Health 5.99 Bn 5.67 Bn 154.23 Mn -
5 10x Genomics 5.91 Bn 5.37 Bn 106.18 Mn 10.14 Mn
6 MiniMed 4.55 Bn 4.25 Bn 480.00 Mn -
7 Waystar Holding 4.48 Bn 4.42 Bn 216.84 Mn 5.16 Mn
8 Doximity 3.96 Bn 3.21 Bn 125.97 Mn 400,000.00
9 Privia Health 3.15 Bn 2.73 Bn - -
10 Claritev 374.74 Mn 340.02 Mn 175.60 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2020 38.50 Mn
Jun 30, 2020 38.50 Mn
Mar 31, 2020 38.50 Mn